209 related articles for article (PubMed ID: 35797024)
1. Efficacy and Safety of Saline Nasal Irrigation Plus Theophylline for Treatment of COVID-19-Related Olfactory Dysfunction: The SCENT2 Phase 2 Randomized Clinical Trial.
Gupta S; Lee JJ; Perrin A; Khan A; Smith HJ; Farrell N; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2022 Sep; 148(9):830-837. PubMed ID: 35797024
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Combined Visual-Olfactory Training With Patient-Preferred Scents as Treatment for Patients With COVID-19 Resultant Olfactory Loss: A Randomized Clinical Trial.
Khan AM; Piccirillo J; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2023 Feb; 149(2):141-149. PubMed ID: 36580304
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of Gabapentin For Post-COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial.
Mahadev A; Hentati F; Miller B; Bao J; Perrin A; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2023 Dec; 149(12):1111-1119. PubMed ID: 37733356
[TBL] [Abstract][Full Text] [Related]
4. Smell Changes and Efficacy of Nasal Theophylline (SCENT) irrigation: A randomized controlled trial for treatment of post-viral olfactory dysfunction.
Lee JJ; Peterson AM; Kallogjeri D; Jiramongkolchai P; Kukuljan S; Schneider JS; Klatt-Cromwell CN; Drescher AJ; Brunworth JD; Piccirillo JF
Am J Otolaryngol; 2022; 43(2):103299. PubMed ID: 34894449
[TBL] [Abstract][Full Text] [Related]
5. Effect of Budesonide Added to Large-Volume, Low-pressure Saline Sinus Irrigation for Chronic Rhinosinusitis: A Randomized Clinical Trial.
Tait S; Kallogjeri D; Suko J; Kukuljan S; Schneider J; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Jul; 144(7):605-612. PubMed ID: 29879268
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Novel At-home Smell Assessment.
Gupta S; Kallogjeri D; Farrell NF; Lee JJ; Smith HJ; Khan AM; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2022 Mar; 148(3):252-258. PubMed ID: 35024772
[TBL] [Abstract][Full Text] [Related]
8. Stellate Ganglion Block for the Treatment of COVID-19-Induced Olfactory Dysfunction: A Prospective Pilot Study.
Peterson AM; Miller BJ; Kallogjeri D; Piccirillo JF; Kukuljan S; Roland LT; Schneider JS; Crock LW; Farrell NF
Otolaryngol Head Neck Surg; 2024 Jan; 170(1):272-276. PubMed ID: 37750244
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction.
Webster KE; O'Byrne L; MacKeith S; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD013877. PubMed ID: 36063364
[TBL] [Abstract][Full Text] [Related]
11. Effective early strategy to prevent olfactory and gustatory dysfunction in COVID-19: a randomized controlled trial.
Jing Q; Song J; An G; Zhu E; Ai Z; Xiong L; Li C
QJM; 2024 Jun; 117(5):348-352. PubMed ID: 37988146
[TBL] [Abstract][Full Text] [Related]
12. Letter to the editor: Study Summary - Randomized Control Trial of Omega-3 Fatty Acid Supplementation for the Treatment of COVID-19 Related Olfactory Dysfunction.
Lerner D; Garvey K; Arrighi-Allisan A; Filimonov A; Filip P; Liu K; Ninan S; Schaberg M; Colley P; Del Signore A; Govindaraj S; Iloreta AM
Trials; 2020 Nov; 21(1):942. PubMed ID: 33225989
[TBL] [Abstract][Full Text] [Related]
13. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
14. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.
Bachert C; Mannent L; Naclerio RM; Mullol J; Ferguson BJ; Gevaert P; Hellings P; Jiao L; Wang L; Evans RR; Pirozzi G; Graham NM; Swanson B; Hamilton JD; Radin A; Gandhi NA; Stahl N; Yancopoulos GD; Sutherland ER
JAMA; 2016 Feb; 315(5):469-79. PubMed ID: 26836729
[TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid nasal irrigation as early treatment of olfactory dysfunction in COVID-19: A prospective randomised controlled trial.
Tragoonrungsea J; Tangbumrungtham N; Nitivanichsakul T; Roongpuvapaht B; Tanjararak K
Clin Otolaryngol; 2023 Mar; 48(2):182-190. PubMed ID: 36336851
[TBL] [Abstract][Full Text] [Related]
17. Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial.
Yan CH; Jang SS; Lin HC; Ma Y; Khanwalkar AR; Thai A; Patel ZM
Int Forum Allergy Rhinol; 2023 Jun; 13(6):989-997. PubMed ID: 36507615
[TBL] [Abstract][Full Text] [Related]
18. Exploring Olfactory Dysfunction as a Marker of Frailty and Postoperative Outcomes in Head and Neck Cancer.
Mady LJ; De Ravin E; Vohra V; Lu J; Newman JG; Hall DE; Dalton PH; Rowan NR
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):828-836. PubMed ID: 37498617
[TBL] [Abstract][Full Text] [Related]
19. Virucidal effect of povidone iodine on COVID-19 in the nasopharynx: A structured summary of a study protocol for an open-label randomized clinical trial.
Hasan MJ; Rumi SKNF; Banu SS; Uddin AKMN; Islam MS; Arefin MK
Trials; 2021 Jan; 22(1):2. PubMed ID: 33397432
[TBL] [Abstract][Full Text] [Related]
20. Nasal saline irrigation has no effect on normal olfaction: a prospective randomized trial.
Liu JJ; Chan GC; Hecht AS; Storm DR; Davis GE
Int Forum Allergy Rhinol; 2014 Jan; 4(1):39-42. PubMed ID: 24574085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
